IMI
Benjamin Kopp, MD, MPH
Pediatrics
Emory University
Robert Gray, MBChB, PhD
Centre for Inflammation Research
University of Edinburgh
This session will focus on exciting changes in interactions between immune cells, pathogens, and inflammatory signaling in the context of CFTR modulator therapy. Attendees will learn about the latest research regarding the impact of highly effective modulators upon airway infection and inflammation. Focused talks will include changing patterns of CF microbiology, new models to analyze the microbiome and bacterial metabolites, adaptive immune responses, and inflammatory signaling, all in the context of CFTR modulators. The session will conclude with a panel discussion of speakers and moderators to synthesize the changing patterns reported and identify barriers and therapeutic options moving forward.
Speaker: Pradeep Singh – University of Washington
Speaker: Robert A. Quinn, PhD – Michigan State University
Speaker: Milene T. Saavedra, MD – National Jewish Health
Speaker: Robert D. Gray, MBChB, PhD – University of Edinburgh